Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Deucravacitinib by Bristol-Myers Squibb for Hidradenitis Suppurativa: Likelihood of Approval
Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData, Phase...
Deucravacitinib by Bristol-Myers Squibb for Ulcerative Colitis: Likelihood of Approval
Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase...
Deucravacitinib by Bristol-Myers Squibb for Sicca Syndrome (Sjogren): Likelihood of Approval
Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase III for Sicca Syndrome (Sjogren). According to GlobalData,...